Viking Therapeutics
VKTX
6 hedge funds and large institutions have $252K invested in Viking Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
34% less capital invested
Capital invested by funds: $384K → $252K (-$132K)
Top Buyers
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$19.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.04K |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$81K |
| 2 |
Goldman Sachs
New York
|
-$34.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $107K | -$34.9K | -5,432 | -23% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $106K | – | – | – |
|
|
3
Creative Planning
Overland Park,
Kansas
| $18K | +$19.3K | +3,000 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $11K | +$10.3K | +1,597 | +522% |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | +$9.04K | +1,408 | New |
|
|
BIM
6
BlackRock Investment Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$81K | -11,403 | Closed |
|
VKTX Hedge Fund Activity: Q3 2015 in Review
6 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2015, worth a combined $252K — down 34% from $384K a quarter earlier.
Fund positioning in VKTX was balanced in Q3 2015: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Creative Planning, opening a new position worth an estimated $19.3K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $81K sold.
- 6 institutional investors held Viking Therapeutics (VKTX) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $252K of Viking Therapeutics stock for Q3 2015, down 34% quarter-over-quarter.
- 2 funds opened new Viking Therapeutics positions in Q3 2015 and 2 closed out, a net change of 0 holders.
- The largest Viking Therapeutics buyer in Q3 2015 was Creative Planning, an estimated $19.3K added.
- The largest Viking Therapeutics seller in Q3 2015 was Virtu KCG Holdings, an estimated $81K sold.
Based on aggregated 13F filings for Q3 2015.